Previous 10 |
Gainers: Maxwell Technologies (NASDAQ: MXWL ) +50% . Therapix Biosciences (NASDAQ: TRPX ) +24% . Continental Materials (NYSEMKT: CUO ) +24% . PHI (NASDAQ: PHII ) +22% . Orgenesis (NASDAQ: ORGS ) +19% . The Ultimate Software Group (NASDAQ: ULTI ) +20% . Aileron Therapeutics (NASDAQ: ...
Thinly traded nano cap Novus Therapeutics ( NVUS +14.9% ) is up on average volume following its updates on clinical trials supporting lead drug OP0201. More news on: Novus Therapeutics, Healthcare stocks news, Stocks on the move, Read more ...
Screening Initiated for Phase 1 Pharmacodynamic Effects Trial (Study C-001) Screening Initiated for Second Cohort of Phase 1 Trial in Healthy Adults (Study C-002) Enrollment Completed in Phase 1 Trial in Adults with Acute Otitis Media (Study C-004) New Phase 2a Trial i...
Gainers: Energous Corporation (NASDAQ: WATT ) +95% . BioXcel Therapeutics (NASDAQ: BTAI ) +81% . CounterPath (NASDAQ: CPAH ) +25% . Novus Therapeutics (NASDAQ: NVUS ) +21% . LiveXLive Media (NASDAQ: LIVX ) +19% . Netshoes (NYSE: NETS ) +17% . Avadel Pharmaceuticals (NASDAQ: AVDL ) ...
Gainers: OKTA +20% . NVUS +17% . XENE +16% . NX +16% . DRNA +15% . ZEAL +15% . SHLO +15% . TIS +13% . FIVE +13% . MCFT +11% . More news on: Okta, Inc., Novus Therapeutics, Xenon Pharmaceuticals, Stocks on the move, , Read more ...
Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (“ENT”), today announced that it has elected to postpone the previously announced public offering of its common st...
NVUS +37% on regaining its 24% slide. More news on: Novus Therapeutics, Okta, Inc., Five Below, Stocks on the move, , Read more ...
Thinly traded nano cap Novus Therapeutics (NASDAQ: NVUS ) is up 41% premarket on increased volume, poised to regain the week's 24% slide and then some. On Tuesday after the close, it announced a 6M-share stock offering although the price was not released. More news ...
News, Short Squeeze, Breakout and More Instantly...
Novus Therapeutics Inc. Company Name:
NVUS Stock Symbol:
NASDAQ Market:
Eledon to commence trading on the Nasdaq exchange under the ticker “ELDN” effective tomorrow, January 5, 2021 Eledon is well financed to complete up to four Phase 2 clinical trials of lead candidate AT-1501, a potential best in class anti-CD40L monoclonal antibody ...
IRVINE, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharmaceutical company focused on developing life-changing, targeted medicines for patients undergoing organ or cellular transplantation, as well as those l...
Former Chief Development and Chief Operating Officer of MyoKardia, Inc. brings extensive clinical development expertise as Novus prepares to conduct up to four Phase 2 clinical trials Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharma...